Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 9340610, 6 pages
https://doi.org/10.1155/2017/9340610
Research Article

Triggering Receptor Expressed on Myeloid Cells 2 Overexpression Inhibits Proinflammatory Cytokines in Lipopolysaccharide-Stimulated Microglia

1Department of Anesthesiology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, 182 Tongguan Road, Lianyungang 222000, China
2Department of Basic Medical Science, Kangda College, Nanjing Medical University, 88 Chunhui Road, Lianyungang 222000, China
3Department of Anesthesiology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing 210008, China

Correspondence should be addressed to Jiying Feng; moc.361@dsyjgnef and Jinwei Zhang; moc.361@289wjz

Received 22 May 2017; Revised 21 August 2017; Accepted 28 September 2017; Published 18 October 2017

Academic Editor: Settimio Rossi

Copyright © 2017 Xiaobao Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Heneka, M. J. Carson, J. El Khoury et al., “Neuroinflammation in Alzheimer’s disease,” Lancet Neurology, vol. 14, pp. 388–405, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Calvello, A. Cianciulli, G. Nicolardi et al., “Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson’s disease, shifting M1 to M2 microglia responses,” Journal of Neuroimmune Pharmacology, vol. 12, no. 2, pp. 327–339, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. Q. Li, D. D. Dong, Q. P. Huang et al., “The anti-inflammatory effect of Sonchus oleraceus aqueous extract on lipopolysaccharide stimulated RAW 264.7 cells and mice,” Pharmaceutical Biology, vol. 55, pp. 799–809, 2017. View at Publisher · View at Google Scholar
  4. L. Qin, X. Wu, M. L. Block et al., “Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration,” Glia, vol. 55, pp. 453–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Giuliani, A. Ottani, L. Neri et al., “Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: therapeutic perspectives,” Progress in Neurobiology, vol. 148, pp. 40–56, 2017. View at Publisher · View at Google Scholar
  6. R. M. Ransohoff and M. A. Brown, “Innate immunity in the central nervous system,” The Journal of Clinical Investigation, vol. 122, pp. 1164–1171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. C. Hirsch, S. Vyas, and S. Hunot, “Neuroinflammation in Parkinson’s disease,” Parkinsonism & Related Disorders, vol. 18, Supplement 1, pp. S210–S212, 2012. View at Publisher · View at Google Scholar
  8. R. B. Maccioni, L. E. Rojo, J. A. Fernandez, and R. O. Kuljis, “The role of neuroimmunomodulation in Alzheimer’s disease,” Annals of the New York Academy of Sciences, vol. 1153, pp. 240–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Colonna and Y. Wang, “TREM2 variants: new keys to decipher Alzheimer disease pathogenesis,” Nature Reviews Neuroscience, vol. 17, pp. 201–207, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Ulrich and D. M. Holtzman, “TREM2 function in Alzheimer’s disease and neurodegeneration,” ACS Chemical Neuroscience, vol. 7, pp. 420–427, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Walter, “The triggering receptor expressed on myeloid cells 2: a molecular link of neuroinflammation and neurodegenerative diseases,” The Journal of Biological Chemistry, vol. 291, pp. 4334–4341, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Frank, G. J. Burbach, M. Bonin et al., “TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice,” Glia, vol. 56, pp. 1438–1447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Jiang, Y. D. Zhang, Q. Chen et al., “TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice,” Neuropharmacology, vol. 105, pp. 196–206, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Takahashi, C. D. Rochford, and H. Neumann, “Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2,” The Journal of Experimental Medicine, vol. 201, pp. 647–657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Zhang, J. Wang, W. Qian et al., “Dexmedetomidine inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated microglia by suppression of extracellular signal-regulated kinase,” Neurological Research, vol. 37, pp. 238–245, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Kettenmann, U. K. Hanisch, M. Noda, and A. Verkhratsky, “Physiology of microglia,” Physiological Reviews, vol. 91, pp. 461–553, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology, vol. 8, pp. 958–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. Zhang, Y. Lu, H. Bian, L. Guo, and H. Zhu, “Activation of the α7 nicotinic receptor promotes lipopolysaccharide-induced conversion of M1 microglia to M2,” American Journal of Translational Research, vol. 9, pp. 971–985, 2017. View at Google Scholar
  19. Y. J. Lee, D. Y. Choi, I. S. Choi et al., “Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models,” Journal of Neuroinflammation, vol. 9, p. 35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. C. H. Hsing, S. K. Hung, Y. C. Chen et al., “Histone deacetylase inhibitor trichostatin A ameliorated endotoxin-induced neuroinflammation and cognitive dysfunction,” Mediators of Inflammation, vol. 2015, Article ID 163140, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Habib, A. Slowik, A. Zendedel, S. Johann, J. Dang, and C. Beyer, “Regulation of hypoxia-induced inflammatory responses and M1-M2 phenotype switch of primary rat microglia by sex steroids,” Journal of Molecular Neuroscience, vol. 52, pp. 277–285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Zhu, N. Yang, Y. Y. Liu, J. Zheng, C. Ji, and P. P. Zuo, “M2 macrophage transplantation ameliorates cognitive dysfunction in amyloid-β-treated rats through regulation of microglial polarization,” Journal of Alzheimer's Disease, vol. 52, pp. 483–495, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Blandini, “Neural and immune mechanisms in the pathogenesis of Parkinson’s disease,” Journal of Neuroimmune Pharmacology, vol. 8, pp. 189–201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Wang, H. Jing, H. Yang et al., “Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson’s disease,” Journal of Ethnopharmacology, vol. 164, pp. 247–255, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. H. J. Park, O. SH, H. N. Kim, Y. J. Jung, and P. H. Lee, “Mesenchymal stem cells enhance α-synuclein clearance via M2 microglia polarization in experimental and human parkinsonian disorder,” Acta Neuropathologica, vol. 132, pp. 685–701, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. Colton, R. T. Mott, H. Sharpe, Q. Xu, W. E. Van Nostrand, and M. P. Vitek, “Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD,” Journal of Neuroinflammation, vol. 3, p. 27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. V. H. Perry, “Contribution of systemic inflammation to chronic neurodegeneration,” Acta Neuropathologica, vol. 120, pp. 277–286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Colonna, “TREMs in the immune system and beyond,” Nature Reviews Immunology, vol. 3, pp. 445–453, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Forabosco, A. Ramasamy, D. Trabzuni et al., “Insights into TREM2 biology by network analysis of human brain gene expression data,” Neurobiology of Aging, vol. 34, pp. 2699–2714, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Matarin, D. A. Salih, M. Yasvoina et al., “A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology,” Cell Reports, vol. 10, pp. 633–644, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Villegas-Llerena, A. Phillips, P. Garcia-Reitboeck, J. Hardy, and J. M. Pocock, “Microglial genes regulating neuroinflammation in the progression of Alzheimer’s disease,” Current Opinion in Neurobiology, vol. 36, pp. 74–81, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Takahashi, M. Prinz, M. Stagi, O. Chechneva, and H. Neumann, “TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis,” PLoS Medicine, vol. 4, article e124, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Zhong, X. F. Chen, Z. L. Zhang et al., “DAP12 stabilizes the C-terminal fragment of the triggering receptor expressed on myeloid cells-2 (TREM2) and protects against LPS-induced pro-inflammatory response,” The Journal of Biological Chemistry, vol. 290, pp. 15866–15877, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. J. R. Pride, “Good leadership skills make top less lonely. Interview by Hugh Doherty,” Dentistry Today, vol. 8, pp. 46–48-49, 1989. View at Google Scholar
  35. T. Jiang, L. Tan, X. C. Zhu et al., “Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer’s disease,” Neuropsychopharmacology, vol. 39, pp. 2949–2962, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Yuan, C. Condello, C. D. Keene et al., “TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy,” Neuron, vol. 90, pp. 724–739, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. P. L. Poliani, Y. Wang, E. Fontana et al., “TREM2 sustains microglial expansion during aging and response to demyelination,” The Journal of Clinical Investigation, vol. 125, pp. 2161–2170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Jiang, Y. Wan, Y. D. Zhang et al., “TREM2 overexpression has no improvement on neuropathology and cognitive impairment in aging APPswe/PS1dE9 mice,” Molecular Neurobiology, vol. 54, pp. 855–865, 2017. View at Publisher · View at Google Scholar · View at Scopus